GlaxoSmithKline said on Wednesday it would shed "several hundred" U.S. commercial jobs and a similar number of research positions as it restructures operations in its biggest market, where drug sales are flagging. Many of the jobs lost will be from GSK's Research Triangle Park site in North Carolina as drug research is consolidated in Philadelphia and in Stevenage, near London. Sources familiar with the matter said at the weekend the drugmaker would inform U.S. staff about the job cuts as it starts implementing a big cost-saving programme, following a sharp decline in sales of its top-selling lung drug Advair. http://yhoo.it/1wu7ZHV http://bit.ly/1fJ5yqZ
GSK Cuts U.S. Sales and Research Jobs as Market Gets Tougher
GlaxoSmithKline said on Wednesday it would shed "several hundred" U.S. commercial jobs and a similar number of research positions as it restructures operations in its biggest market, where drug sales are flagging. Many of the jobs lost will be from GSK's Research Triangle Park site in North Carolina as drug research is consolidated in Philadelphia and in Stevenage, near London. Sources familiar with the matter said at the weekend the drugmaker would inform U.S. staff about the job cuts as it starts implementing a big cost-saving programme, following a sharp decline in sales of its top-selling lung drug Advair. http://yhoo.it/1wu7ZHV http://bit.ly/1fJ5yqZ
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment